-
EP3468500
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3468500
| EP3468500 - SILANOL BASED THERAPEUTIC PAYLOADS [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 09.04.2021 Database last updated on 03.08.2024 | |
| Former | Request for examination was made Status updated on 15.03.2019 | ||
| Former | The international publication has been made Status updated on 16.12.2017 | Most recent event Tooltip | 27.06.2023 | New entry: Renewal fee paid | Applicant(s) | For all designated states Blinkbio Inc. The Scripps Research Institute 130 Scripps Way Jupiter, FL 33458 / US | [2019/16] | Inventor(s) | 01 /
WANNER, Jutta 227 Oleander Ave Palm Beach FL 33480 / US | 02 /
NGUYEN, Hanh Nho 132 Stonebriar Blvd. Jupiter FL 33458 / US | 03 /
WERNER, Douglas S. 312 Bamboo Road West Palm Beach FL 33404 / US | 04 /
OFORI, Leslie Odame 500 W Whitney Dr. Jupiter FL 33458 / US | [2019/16] | Representative(s) | Harris, Jennifer Lucy, et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB | [2019/16] | Application number, filing date | 17811071.4 | 09.06.2017 | [2019/16] | WO2017US36728 | Priority number, date | US201662347700P | 09.06.2016 Original published format: US 201662347700 P | US201662349274P | 13.06.2016 Original published format: US 201662349274 P | US201762477695P | 28.03.2017 Original published format: US 201762477695 P | [2019/16] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017214491 | Date: | 14.12.2017 | Language: | EN | [2017/50] | Type: | A1 Application with search report | No.: | EP3468500 | Date: | 17.04.2019 | Language: | EN | The application published by WIPO in one of the EPO official languages on 14.12.2017 takes the place of the publication of the European patent application. | [2019/16] | Search report(s) | International search report - published on: | US | 14.12.2017 | (Supplementary) European search report - dispatched on: | EP | 30.01.2020 | Classification | IPC: | A61K31/695, A61K9/00, A61K47/54, A61K47/55, A61K47/60, A61K47/64, C07F5/02, C07F7/08, C07F15/00 | [2020/10] | CPC: |
A61K31/695 (EP,US);
A61K47/542 (EP,US);
A61K47/545 (US);
A61K47/551 (EP,US);
A61K47/555 (US);
A61K47/60 (EP,US);
A61K47/64 (EP,US);
A61K9/0097 (EP,US);
A61P29/00 (EP);
A61P3/00 (EP);
A61P31/00 (EP);
A61P31/12 (EP);
A61P35/00 (EP,US);
C07F15/0093 (EP,US);
C07F5/022 (EP,US);
|
| Former IPC [2019/16] | A61C5/30 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/16] | Extension states | BA | 08.01.2019 | ME | 08.01.2019 | Validation states | MA | 08.01.2019 | MD | 08.01.2019 | Title | German: | THERAPEUTISCHE NUTZLASTEN AUF SILANOLBASIS | [2019/16] | English: | SILANOL BASED THERAPEUTIC PAYLOADS | [2019/16] | French: | CHARGES UTILES THÉRAPEUTIQUES À BASE DE SILANOL | [2019/16] | Entry into regional phase | 08.01.2019 | National basic fee paid | 08.01.2019 | Search fee paid | 08.01.2019 | Designation fee(s) paid | 08.01.2019 | Examination fee paid | Examination procedure | deleted | Date on which the examining division has become responsible | 08.01.2019 | Examination requested [2019/16] | 18.09.2020 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time | 24.11.2020 | Amendment by applicant (claims and/or description) | 12.04.2021 | Despatch of a communication from the examining division (Time limit: M06) | 13.10.2021 | Reply to a communication from the examining division | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 24.11.2020 | Request for further processing filed | 24.11.2020 | Full payment received (date of receipt of payment) Request granted | 03.12.2020 | Decision despatched | Fees paid | Renewal fee | 27.06.2019 | Renewal fee patent year 03 | 27.10.2020 | Renewal fee patent year 04 | 28.06.2021 | Renewal fee patent year 05 | 27.06.2022 | Renewal fee patent year 06 | 27.06.2023 | Renewal fee patent year 07 | Penalty fee | Additional fee for renewal fee | 30.06.2020 | 04 M06 Fee paid on 27.10.2020 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO2009051580 (BIONUMERIK PHARMACEUTICALS INC [US], et al) [X] 11-14* compound 46 *; | [XP]WO2016183359 (BLINKBIO INC [US]) [XP] 1-15 * the whole document * * paragraph [0040]; figure 1; example 82; claims 20-32 * | International search | [A]US2005002942 (VLAHOV IONTCHO R [US], et al) [A] 1-3, 17-20* ; entire document *; | [A]WO2006069096 (AXYS PHARM INC [US], et al) [A] 1-3, 17-20 * ; entire document *; | [X]US2012165522 (CAI XIAOHONG [US], et al) [X] 17-20 * ; p17, para[0060], para[0118], para[0193], para[0277] *; | [A]US2014274951 (GUZZO PETER R [US], et al) [A] 1-3, 17-20 * ; entire document *; | [A]US2015374849 (KNIPP RALPH J [US], et al) [A] 1-3 * ; para[0126], para[0265], para[0333] *; | [A] - WU et al., "Oxidation-Triggered Release of Fluorescent Molecules or Drugs from Mesoporous Si Microparticles", ACS Nano, (20081108), vol. 2, no. 11, pages 2401 - 2409, XP055457131 [A] 1-3 * ; p2402, p2405 * DOI: http://dx.doi.org/10.1021/nn800592q | [A] - MCCUSKER et al., "Cationic polyhedral oligomeric silsesquioxane (POSS) units as carriers for drug delivery processes", Chemical Communications, (20050110), pages 996 - 998, XP055457135 [A] 1-3 * ; Title, p996 * DOI: http://dx.doi.org/10.1039/b416266h | [A] - LJUNGMAN et al., "The anti-cancer drug camptothecin inhibits elongation but stimulates initiation of RNA polymerase II transcription", Carcinogenesis, (19960101), vol. 17, no. 1, pages 31 - 36, XP055457137 [A] 17 * ; p31 * DOI: http://dx.doi.org/10.1093/carcin/17.1.31 |